Shionogi
Clinical trials sponsored by Shionogi, explained in plain language.
-
New hope for Tough-to-Treat cancers: experimental drug trial opens
Disease control Recruiting nowThis study is testing a new drug called S-531011 for people with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose and see if the drug, given alone or with other cancer therapies, can shrink tumors. It is for adults who…
Phase: PHASE1, PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New pill aims to stop RSV in its tracks for vulnerable adults
Disease control Recruiting nowThis study is testing an oral drug called S-337395 to see if it can help adults with RSV who are at high risk for severe illness. The goal is to see if the drug can reduce the amount of virus in the body and help people feel better faster. Participants are adults with recent RSV …
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for pompe patients: trial tests Add-On to standard therapy
Disease control Recruiting nowThis study is testing whether adding an investigational drug called S-606001 to standard enzyme replacement therapy (ERT) is safe and can help adults with late-onset Pompe disease. It will measure changes in breathing, walking ability, muscle strength, and fatigue over one year. …
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
First human test: how kidneys handle new drug
Knowledge-focused Recruiting nowThis early-stage study aims to understand how a new drug, S-892216, behaves in the body of people with different levels of kidney function. It will enroll 40 participants, some with healthy kidneys and some with mild to severe kidney problems, including some on dialysis. The main…
Phase: PHASE1 • Sponsor: Shionogi • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC